Predictive Factors of Autonomy Loss in Real-life Cohort

Recruiting N/A Interventional Study
Memory Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
5,400 (estimated)
Sponsor
Hospices Civils de Lyon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years and older, undergoing a medical visit in a memory center or neuro-cognition service * Patients living at home or in housing * Patients with memory impairment, at all stage of the disease Exclusion Criteria: * Patients in institution * Patients under le…
Contacts

Pierre Krolak-Salmon, PhD

04 72 43 20 50

pierre.krolak-salmon@chu-lyon.fr

CONTACT